. 2020 Jun 17;51(7):2087–2094. doi: 10.1161/STROKEAHA.119.028418
© 2020 The Authors.
Stroke is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Table 3.
Secondary Efficacy End Points at 12-Month Follow-Up
